AcelRx inks deal with Zimmer Biomet to distribute Dsuvia
Zimmer Biomet’s (NYSE:ZBH) Dental division has agreed to distribute AcelRx Pharmaceuticals’ (NASDAQ:ACRX) opioid pain med Dsuvia (sufentanil sublingual tablet) within the U.S. dental and oral surgery markets. Financial terms are not disclosed.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.